104. Horikawa, Y., Matsumura, I., Hashimoto, K., Shiraga, M.,
Kosugi, S., Tadokoro, S., Kato, T., Miyazaki, H., Tomiyama, Y.,
Kurata, Y., Matsuzawa, Y., and Kanakura, Y. Markedly reduced
expression of platelet c-mpl receptor in essential thrombocythemia.
Blood,
90:4031-4038, 1997.
103. Kosugi, S., Imai, Y., Kurata, Y., Tomiyama, Y., Shiraga, M.,
Honda, S., Nishikawa, M., Yonezawa, T., Kanakura, Y., and Matsuzawa,
Y. Platelet-associated IgM elevated in patients with chronic
hepatitis C contains no anti-platelet autoantibodies.
Liver,
17:230-237, 1997.
102. Oritani, K., Kanakura, Y., Aoyama, K., Yokota, T., Copeland,
N. G., Gilbert, D. J., Jenkins, N. A., Tomiyama, Y., Matsuzawa, Y.,
and Kincade, P. W. Matrix glycoprotein SC1/ECM2 augments B
lymphopoiesis.
Blood,
90:3404-3413, 1997.
101. Tsujimura, T., Hashimoto, K., Morii, E., Arnheiter, H.,
Tunio, G. M., Tsujino, K.,Kondo, T., Kanakura, Y., and Kitamura, Y.
Involvement of transcription factor encoded by the mouse mi locus
(MITF) in apoptosis of cultured mast cells induced by removal of
interleukin-3.
Am.
J. Pathol., 151:1043-1051, 1997.
100. Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R.,
Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M.,
Misawa, H., Miyazaki,T., Leonor, N., Taniguchi, T., Fujita, T.,
Kanakura, Y., Komiya, S., and Yoshimura, A. A new protein containing
an SH2 domain that inhibits JAK kinases.
Nature,
387:921-924, 1997.
99. Matsumura, I., Ishikawa, J., Nakajima, K., Oritani, K.,,
Tomiyama, Y., Kato, T., Miyazaki, H., Matsuzawa, Y., and Kanakura, Y.
Thrombopoietin-induced differentiation of a human megakaryoblastic
leukemia cell line, CMK, involves transcriptional activation of
p21WAF1/Cip1 by STAT5.
Mol.
Cell. Biol., 17:2933-2943, 1997.
98. Nomura, S., Ogami, K., Kawamura, K., Kudo, Y., Kanakura, Y.,
Kitamura, Y., Miyazaki, H., and Kato, T. Cellular localization of
thrombopoietin mRNA in the liver by in situ hybridization.
Exp.
Hematol., 25:565-572, 1997.
97. Tsujimura, T., Kanakura, Y., and Kitamura, Y. Mechanisms of
constitutive activation of c-kit receptor tyrosien kinase.
Leukemia,
11 (suppl.):396-398, 1997.